Dose Frequency News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dose Frequency. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dose Frequency Today - Breaking & Trending Today

Novel Antibody May Reduce Amyloid, Cut AD Symptoms

Published: April 12, 2022

Lecanemab can reduce amyloid plaques within the first months after treatment initiation and is linked to improved clinical signs in as early as 6 months, updates from a phase 2 trial show.

Source: medscape.com

Related Topics:

United StatesFernando TestaiAmerican Academy Of NeurologyEisai PharmaceuticalsUniversity Of Illinois At ChicagoChad SwansonAmerican AcademyAmyloid PlaquesKey DriverBest DoseDose FrequencyAlzheimers DiseaseLzheimer DiseaseIological MarkerPositron Emission Tomography Pet Positron Emission TomographyCognitive ImpairmentMild Cognitive Impairment